Frontlight ResearchEarly access
SuspendedNo phase
Protocol to Validate the Performance of the LifeKit® Prevent Colorectal Neoplasia Test for CRC Screening
Key facts
- Who runs it
- Metabiomics Corp
- Where
- Carlsbad, United StatesSee the site
- Trial code
- Status
- Suspended
- People taking part
- 12,000 people, planned
- Started
- 1 Mar 2026
- Expected to end
- 1 Mar 2028
- Type of study
- Observational
- Treatments tested
- LifeKit Prevent Colorectal Neoplasia Test
- FIT Test
- Record updated
- 26 September 2025
- Why it stopped
- fundraising
Who can take part
- Age
- 40 years and older
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 14 criteriaShow less
Who can take part
- An individual must meet all of the criteria below to be eligible
- Subject is ≥ 40 years of age at the time of enrollment
- Subject presents for a screening colonoscopy per standard of care
- Subject has no symptoms or signs that require immediate, or near term, referral for diagnostic or therapeutic colonoscopy
- Subject is able and willing to sign informed consent
Who cannot take part
- Subject has had a positive Cologuard, fecal occult blood test or FIT within the previous 2 years
- Subject has undergone a colonoscopy within the previous 9 years
- Subject has had overt rectal bleeding within the previous 30 days
- Subject has a history of CRC or advanced precancerous lesions
- Subject has a diagnosis or medical history of any of the following conditions:; Familial adenomatous polyposis (also referred to as "FAP", including attenuated FAP and Gardner's syndrome); Hereditary non-polyposis CRC syndrome (also referred to as "HNPCC" or "Lynch Syndrome"); Other hereditary cancer syndromes, including but are not limited to, Peutz-Jeghers Syndrome, MYH-Associated Polyposis (MAP), Turcot's (or Crail's) Syndrome, Cowden's Syndrome, Juvenile Polyposis, Neurofibromatosis, or Familial Hyperplastic Polyposis
- Subject has a diagnosis or personal history of inflammatory bowel disease (IBD), including chronic ulcerative colitis or Crohn's disease
- Subject has a diagnosis of Cronkhite-Canada Syndrome
- Subject has any condition that in the opinion of the Investigator should preclude participation in the study
- An individual meeting any of the below criteria is ineligible
Where in United States
- Solvd HealthCarlsbad, United States
About the trial
What the trial wants to find out
The purpose of this study is to determine the sensitivity and specificity for LifeKit Prevent Colorectal Neoplasia Test for colorectal cancer (CRC) and for adenoma, including advanced adenoma.
Treatments tested
- LifeKit Prevent Colorectal Neoplasia Test
- FIT Test
Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Subject Enrollment and Specimen Collection Protocol to Validate the Performance of the LifeKit® Prevent Colorectal Neoplasia Test for Colorectal Cancer Screening
- Record updated
- 26 September 2025